SupplementsThe evidence on black cohosh is genuinely split: Cochrane found no difference from placebo on hot flush frequency, while a 2023 meta-analysis of 22 trials found a small significant benefit. The Menopause Society does not recommend it. Liver injury cases are rare but documented, and species adulteration is the likely culprit — which makes verified sourcing the most important buying criterion. Our top pick is Remifemin.
How We Picked
This category is unusual: the safety question outranks the efficacy question. NIH LiverTox assigns black cohosh products a likelihood score of A for causing liver injury while noting that many implicated products contained Chinese Actaea species rather than authentic black cohosh. So we prioritised species-verified sourcing and third-party testing above everything else, then the extract type used in trials, then standardisation to triterpene glycosides and dose relative to the trial median.
A. Remifemin Menopause Relief — Best Overall
Remifemin Menopause Relief
Remifemin
- Isopropanolic black cohosh extract (iCR)
- The specific extract used in published trials
- Standardised, hormone-free formula
- 40 mg root and rhizome per daily dose
- Decades of post-market use in Europe
Why we picked it: If you are going to test black cohosh on yourself, use the preparation that was actually tested. A randomised, multicentre, double-blind trial in 304 women used tablets corresponding to 40 mg daily of this extract for 12 weeks and found a statistically significant benefit over placebo on the Menopause Rating Scale. Be aware that several authors of that trial were employed by the manufacturer — a real limitation we cover below.
B. Nature's Way Black Cohosh Root — Best Value
Nature's Way Black Cohosh Root
Nature's Way
- Standardised to triterpene glycosides
- TRU-ID authenticated for species identity
- Vegan capsules
- Widely available
- Low cost per day
Why we picked it: Species identity is the whole safety story in this category, and Nature's Way puts its black cohosh through DNA-based TRU-ID authentication. Given that LiverTox notes many liver-injury cases involved products containing Chinese Actaea species rather than authentic black cohosh, a botanical identity test is worth more than any marketing claim.
C. Pure Encapsulations Black Cohosh 2.5 — Best Third-Party Tested
Pure Encapsulations Black Cohosh 2.5
Pure Encapsulations
- Standardised to 2.5% triterpene glycosides
- Free of common allergens and excipients
- Third-party tested for identity and purity
- Vegetarian capsule
- Single-ingredient formula
Why we picked it: The NIH notes products are typically standardised to at least 1 mg of triterpene glycosides per daily dose. A 2.5% standardisation on a clean single-ingredient capsule makes the actual delivered dose easy to calculate, which matters when you are trying to match a trial regimen rather than guess.
The Evidence Is Split, and the Split Is Not Random
Almost every article about black cohosh picks a side. The literature does not support that, so here is both.
Against. The Cochrane review of 16 randomised trials in 2,027 peri- and postmenopausal women found no difference from placebo in hot flush frequency (mean difference 0.07 flushes per day, 95% CI −0.43 to 0.56), and concluded there is currently insufficient evidence to support the use of black cohosh for menopausal symptoms. The best single trial, the year-long HALT study in 351 women aged 45 to 55, found herbal arms differed from placebo by less than 0.55 symptoms per day at any timepoint — while hormone therapy in the same trial produced a reduction of 4.06 symptoms per day (95% CI −5.93 to −2.19). HALT used 160 mg daily, four times the typical dose, and still found nothing.
For. A 2023 pairwise meta-analysis of 22 randomised trials in 2,310 menopausal women found black cohosh beat placebo on overall menopausal symptoms (Hedges' g = 0.575, 95% CI 0.283–0.867) and on hot flashes specifically (g = 0.315, 95% CI 0.107–0.524). Anxiety and depressive symptoms did not improve. NCCIH has since updated its consumer page to reflect this, describing black cohosh as potentially beneficial for overall menopause symptoms.
A Hedges' g of 0.315 is a small effect. That is the honest ceiling: a modest reduction in hot flashes, nothing for mood, in a literature where the larger effect sizes come disproportionately from industry-authored work.
What the Menopause Society Says
The 2023 nonhormone therapy position statement of The North American Menopause Society places black cohosh in the not recommended category for vasomotor symptoms, at Level I evidence, citing the Cochrane finding of no significant difference from placebo. The statement also notes that the active ingredients in black cohosh extract are unknown and its mechanism of action unclear.
One timing detail worth knowing: that position statement was published in June 2023, and the positive pairwise meta-analysis appeared the following month in the same journal. The Society's assessment does not incorporate it. That does not overturn the recommendation, but it is why you will see apparently contradictory expert positions dated within weeks of each other.
The Industry-Authorship Problem
The most positive black cohosh literature concerns the isopropanolic extract sold as Remifemin, and it needs a disclosure. A 2021 review and meta-analysis of that extract reported a standardised mean difference of −0.694 against placebo for neurovegetative and psychological symptoms — a much larger effect than the general literature. Several of its authors are employees of the manufacturer. The same is true of the flagship 2005 randomised trial: four of six authors were employed by the company, and while the result was statistically significant at P < 0.001, the effect size was 0.03 to 0.05 Menopause Rating Scale units.
This does not make the findings false. It does mean you should weight the independent Cochrane and HALT results at least as heavily, and expect a small effect if you get one at all.
Liver Safety: The Part That Matters Most
Two NIH resources disagree about causality here, and both are worth reading before you buy. NIH LiverTox assigns black cohosh a likelihood score of A — meaning products sold as black cohosh are well-established causes of clinically apparent liver injury — documenting more than 50 cases with a typical latency of 2 to 12 weeks, a predominantly hepatocellular pattern, and severity ranging from asymptomatic enzyme elevation to acute liver failure requiring transplantation or resulting in death. Crucially, LiverTox notes that many implicated products contained Chinese Actaea species rather than authentic black cohosh, which confounds causality.
The NIH Office of Dietary Supplements takes a different view, citing at least 83 reported cases of liver damage but stating there is no evidence of a causal relationship, possibly reflecting impurities or species misidentification. The United States Pharmacopeia nonetheless requires the label warning: discontinue use and consult a healthcare practitioner if you have a liver disorder or develop symptoms of liver trouble.
The practical conclusion is not "avoid black cohosh." It is that botanical identity verification is the single most important thing you are buying, because the leading hypothesis is that the injuries came from a different plant sold under the same name. Stop immediately and seek medical advice if you develop jaundice, dark urine, right upper abdominal pain or unexplained fatigue.
Is It Estrogenic? Nobody Actually Knows
You will read confident claims in both directions. The accurate position is uncertainty. The Menopause Society says the active ingredients and mechanism are unknown. The NIH suggests it may act through serotonergic pathways, as an antioxidant or anti-inflammatory, or as a selective estrogen receptor modulator, with mixed results on whether it changes estrogen, LH or FSH levels. NCCIH states plainly that it is uncertain whether black cohosh is safe for women who have had hormone-sensitive conditions such as breast or uterine cancer. The only flat reassurance on this point comes from the manufacturer-authored review. If you have a history of hormone-sensitive cancer, this is a decision for your oncologist, not for a supplement label.
Dose and Duration
The NIH reports that trials have used 8 to 160 mg per day of extract, with a median of 40 mg, standardised to at least 1 mg of triterpene glycosides per daily dose, over durations of 8 to 54 weeks with a mean of about 23 weeks. Remifemin supplies 40 mg of root and rhizome per daily dose across two tablets. Safety data extend to roughly one year and essentially nothing beyond that, so open-ended use is not supported by evidence.
If Black Cohosh Does Not Work For You
Given a realistic ceiling of a small reduction in hot flashes, plenty of women will get nothing. Give it 8 to 12 weeks, then stop if there is no change — do not keep taking it indefinitely on the theory that it is working invisibly. Our guides to vitamins for menopause and perimenopause supplements cover the alternatives, and the HALT comparison is worth remembering: hormone therapy reduced symptoms by more than four per day in the same trial where black cohosh managed under 0.55. If symptoms are disrupting your life, that conversation with a clinician is the higher-yield one.
Frequently Asked Questions
Does black cohosh actually help hot flashes?
The evidence is split. The Cochrane review of 16 trials in 2,027 women found no difference from placebo in hot flush frequency, while a 2023 meta-analysis of 22 trials in 2,310 women found a small but statistically significant benefit (Hedges' g = 0.315 for hot flashes). Even the positive result is a small effect, and neither analysis found improvement in anxiety or depression.
Is black cohosh bad for your liver?
Cases of liver injury are documented but rare, and causality is disputed between NIH bodies. LiverTox assigns a likelihood score of A based on more than 50 cases, while the NIH Office of Dietary Supplements cites at least 83 cases but says there is no evidence of a causal relationship. Many implicated products contained Chinese Actaea species rather than authentic black cohosh, which is why species-verified sourcing matters. Stop and seek medical advice if you develop jaundice, dark urine or unexplained fatigue.
How much black cohosh should I take?
Trials have used 8 to 160 mg of extract daily with a median of 40 mg, standardised to at least 1 mg of triterpene glycosides per daily dose. Remifemin supplies 40 mg of root and rhizome across two tablets daily. Trial durations ranged from 8 to 54 weeks, averaging about 23 weeks, and safety data do not extend much beyond a year.
Is black cohosh safe if I have had breast cancer?
Nobody can currently answer that with confidence. NCCIH states it is uncertain whether black cohosh is safe for women who have had hormone-sensitive conditions such as breast or uterine cancer, and both the Menopause Society and NIH describe its mechanism as unknown. This is a decision to make with your oncologist.
How long before black cohosh works?
Trials typically ran 12 weeks or longer before assessing the primary outcome. If you are going to see an effect, 8 to 12 weeks is a reasonable trial period. Given that safety data extend to about one year and no further, indefinite use is not supported.
Quick Comparison
| Product | Key Feature | Best For |
|---|---|---|
| Remifemin Menopause Relief | The isopropanolic extract used in the clinical trials | Best Overall |
| Nature's Way Black Cohosh Root | Standardised triterpene glycosides at a low cost | Best Value |
| Pure Encapsulations Black Cohosh 2.5 | 2.5% triterpene glycoside standardisation, hypoallergenic | Best Third-Party Tested |
Bottom Line: Which Should You Buy?
For most people: the Remifemin Menopause Relief. The isopropanolic extract used in the clinical trials
Runner-up: the Nature's Way Black Cohosh Root. Standardised triterpene glycosides at a low cost
Also great: the Pure Encapsulations Black Cohosh 2.5. 2.5% triterpene glycoside standardisation, hypoallergenic
Ready to buy?
Jump straight to our top picks on Amazon.
Sources & Research
Every clinical claim on this page links to the study it came from. The Supplements Corner Editorial Team reads the published literature directly — follow any citation below to read the source yourself.
Dosage Reference
Trials have used 8–160 mg of black cohosh extract daily, with a median of 40 mg, standardised to at least 1 mg of triterpene glycosides per daily dose; the isopropanolic extract used in most published trials supplies 40 mg of root and rhizome across two tablets. Typical trial duration was 8 to 54 weeks, averaging about 23 weeks, and safety data extend to roughly one year. Discontinue and consult a healthcare practitioner if you have a liver disorder or develop symptoms of liver trouble — jaundice, dark urine, right upper abdominal pain or unexplained fatigue. Do not use in pregnancy. Speak to your oncologist first if you have a history of hormone-sensitive cancer.
Key Studies Referenced:
- Leach MJ, Moore V (2012). "Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews."
- Newton KM, et al. (2006). "Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Annals of Internal Medicine."
- Sadahiro R, et al. (2023). "Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis. Menopause."
- Castelo-Branco C, et al. (2021). "Review and meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms — an update on the evidence. Climacteric."
- Osmers R, et al. (2005). "Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstetrics and Gynecology."
- The North American Menopause Society (2023). "The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause."
- National Institute of Diabetes and Digestive and Kidney Diseases (2025). "Black Cohosh. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, NCBI Bookshelf."
- National Institutes of Health, Office of Dietary Supplements (2020). "Black Cohosh: Fact Sheet for Health Professionals. NIH ODS."
- National Center for Complementary and Integrative Health (2024). "Black Cohosh: Usefulness and Safety. NCCIH."
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen. Individual results may vary.
